NovaBay Pharmaceuticals, Inc. Announces Executive Appointments
November 12, 2021 at 06:02 am EST
Share
In connection with the completion of the acquisition of DERMAdoctor, on November 5, 2021, NovaBay Pharmaceuticals, Inc. announced that Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor's Chief Product Officer and President, respectively. Dr. Audrey Kunin, age 62, co-founded DERMAdoctor and has served as the Chief Creative Officer of DERMAdoctor since March 2018 and as the Chief Executive Officer and its predecessor since 1998. Dr. Jeff Kunin, age 59, co-founded DERMAdoctor and has served as the President and Chief Executive Officer of DERMAdoctor since March 2018.
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.